InvestorsHub Logo
Followers 4
Posts 372
Boards Moderated 0
Alias Born 08/13/2019

Re: marzan post# 229018

Wednesday, 11/20/2019 8:04:52 PM

Wednesday, November 20, 2019 8:04:52 PM

Post# of 429019

But Amarin didn't claim they reduce cholestrol with the statin combo. Whereas GILD claims they treat NASH where RIt has NASH data and Mochida has NAS patent.



Amarin may have the data, but patents in the US are approved on a first-to-file basis. Besides, patents can come in many flavors. Amarin is still free to file a patent for treatment using Vascepa only, whereas Gilead may file theirs as a combination with their proprietary drug.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News